Nicholas Saraceno, Editor

Stem Cell Reports takes a look at DTC online advertising claims that these are ‘immune boosters.’

JMA Journal report describes how businesses in this Asian-Pacific nation are employing various strategies to reduce GHG emissions.

Session explains how to use this information to help bolster market intelligence, market access, and affordability strategies.

Conference presentation explores groundbreaking topics impacting the pharma industry.

Session explores how on-market products have done, and what to expect from new biosimilars.

Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle.

Study describes how biotech startups can avoid competing with large pharma companies for financing.

Determination will affect future vaccine cost and accessibility, including in developing countries.

Raphael Chin Fo Sieeuw offers his insight on how to address the sector’s most prominent issues, including how to limit the industry’s carbon footprint.

The panel digs deeper into the challenges that women in the life sciences sector face.

Conference hosts roundtable chats, with topics ranging from data-driven decision making to cold chain logistics.

LogiPharma session reminds attendees of what to review, as far as DSCSA compliance is concerned.

How the links of the supply chain are fighting to preserve quality service, even against factors that may be out of their hands.

A reflection on my time with Pharma Commerce thus far, and a plan of action for moving the brand forward.

Pharma Commerce converges on Nation's Capital for HDA Traceability Seminar.

Jason Cook uncovers ways in which pharma companies can plan for weather-related challenges that may arise.

Stakeholders uncover the obstacles surrounding the industry onboarding process.

Attendees meet to discuss operational issues related to traceability implementation.

Session offers information on industry readiness, plus an overview of a phase implementation recommendation.

Event’s first session aims to analyze the legislation’s implementation, as FDA enforcement is delayed until November 2024.

In this PC Podcast episode, Susanne Katus discusses the increasing number of regulations impacting both pharma and biotech companies.

As Pharma Commerce continues to increase its conference exposure, it all could not have been possible without the help of colleagues.

Pharma Commerce team attends DIA's Annual Meeting for the first time.

Micah Litow, Kalderos’ president and COO, discusses the importance of identifying and resolving noncompliant discount requests, along with addressing the gross-to-net gap for drug manufacturers.

Panel explores challenges that could affect their development.

Session offers a look into the Inflation Reduction Act’s impact on market conditions.

Session explores practicality of models for selling low-cost drugs.

The legislation’s deadline for compliance is knocking on the door. Pharma Commerce offers a synopsis of how the Drug Supply Chain Security Act has progressed over the past decade.

How these sets of requirements were developed, and the future outlook on track-and-trace over the next decade.

Sy Pretorius, COO & president of outsourced solutions at Eversana, dives into his new role in the space, after being a veteran in the clinical development sector.